论文部分内容阅读
目的观察米非司酮联合依沙吖啶终止中期妊娠的临床效果、并发症及副反应。方法选择孕14-30周,要求终止妊娠的妇女200例,随机分成观察组和对照组。两组均经腹壁羊膜腔注射依沙吖啶100mg,观察组同时口服米非司酮50mg,每间隔12小时1次,总量150mg,观察两组引产效果、并发症及副反应。结果两组引产成功率均为100%。观察组注药到胎儿娩出时间明显短于对照组(p<0.01);产后2h出血量、胎盘胎膜残留率及软产道损伤率明显低于对照组(p<0.05);观察组仅有轻度恶心及头晕等副反应,对照组无明显副反应。结论米非司酮联合依沙吖啶终止中期妊娠引产时间短、产后出血少、清宫率低,是安全、有效的方法。
Objective To observe the clinical effects, complications and side effects of mifepristone combined with ethacridine in the termination of midterm pregnancy. METHODS: A total of 200 pregnant women, who were pregnant for 14-30 weeks and were required to terminate pregnancy, were randomly divided into observation group and control group. Both groups were injected amniacin 100mg in the amniotic cavity through the abdominal wall. The observation group was given oral mifepristone 50mg once every 12 hours with a total amount of 150mg. The effect, complications and side effects of the two groups were observed. Results The success rate of induction of labor in both groups was 100%. The injection time to the fetus in the observation group was significantly shorter than that in the control group (p <0.01); the amount of bleeding, the residual rate of fetal membranes and the rate of soft birth canal injury were significantly lower than those in the control group (P <0.05) Degree of nausea and dizziness and other side effects, no significant side effects in the control group. Conclusion Mifepristone combined with ethacridine termination of midterm pregnancy short induction of labor, less postpartum hemorrhage, clearance rate is low, is a safe and effective method.